Author

Andreas Lazar 1

1 Ab

ASSESSMENT OF IMPACT III WELL-BEING DOMAIN SCORES IN ADALIMUMAB-TREATED PAEDIATRIC PATIENTS WITH CROHN'S DISEASE

Amy Grant, Anthony R. Otley, Johanna Caroline Escher, Jeffrey S Hyams, Jen-Fue Maa, Gabriela Alperovich, Andreas Lazar, Anne M. Robinson, Anthony W. Wang, Samantha Eichner

BURDEN OF DISEASE IN PAEDIATRIC PATIENTS WITH MODERATE VERSUS SEVERE CROHN’S DISEASE IN THE IMAGINE 1 TRIAL

Frank Ruemmele, Jeffrey S Hyams, Joel Rosh, Marla C. Dubinsky, James Markowitz, Anne Griffiths, Dan Turner, Samantha Eichner, Andreas Lazar, Anne M. Robinson, Bidan Huang, Roopal B Thakkar

DIFFERENT METHODOLOGIES FOR DETERMINING MAYO SCORE IN CLINICAL STUDIES CAN INFLUENCE DISEASE ACTIVITY ASSESSMENTS IN ULCERATIVE COLITIS

Subrata Ghosh, William Sandborn, Julian Panés, Geert R. D'Haens, Nattanan Reilly, Andreas Lazar, Bidan Huang, Anne M. Robinson, Roopal B Thakkar

EARLY RESPONSE TO TREATMENT WITH ADALIMUMAB IN CHILDREN WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS FROM IMAGINE 1

Jaroslaw Kierkuś, Wallace Crandall, Robert Baldassano, Andreas Lazar, Yacin Wang, Samantha Eichner, Jeffrey S Hyams, Roopal B Thakkar

EFFECT OF ADALIMUMAB ON CLINICAL AND HEALTH-RELATED QUALITY OF LIFE OUTCOMES BY DISEASE SEVERITY AND PRIOR TUMOUR NECROSIS FACTOR INHIBITOR USE IN PATIENTS WITH ULCERATIVE COLITIS IN A CLINICAL PRACTICE SETTING: SUBGROUP ANALYSES FROM INSPIRADA

Simon Travis, Brian G. Feagan, Laurent Peyrin-Biroulet, Remo Panaccione, Silvio Danese, Joel Petersson, Andreas Lazar, Anne M. Robinson, Naijun Chen, Martha Skup, Wan-Ju Lee

EFFECT OF ADALIMUMAB ON PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS IN ITALIAN CLINICAL PRACTICE SETTING: RESULTS FROM INSPIRADA

Anna Kohn, Livia Biancone, Paolo Gionchetti, Silvio Danese, Ambrogio Orlando, Andreas Lazar, Anne M. Robinson, Brandee L Pappalardo, Mareike Bereswill, Martha Skup, Naijun Chen, Rocco Merolla, Song Wang, Roopal B Thakkar, Simon Travis

EFFICACY AND SAFETY OF ADALIMUMAB IN PEDIATRIC PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS OF A RANDOMIZED-CONTROLLED PHASE 3 STUDY

Nicholas M. Croft, William A Faubion, Subra Kugathasan, Jaroslaw Kierkuś, Frank Ruemmele, Nael M. Mostafa, Mary Venetucci, Tricia Finney-Hayward, Mareike Bereswill, Andreas Lazar, Dan Turner

EFFICACY OF ADALIMUMAB FOR TREATMENT OF PERIANAL FISTULA IN CHILDREN WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS FROM IMAGINE 1

Frank Ruemmele, Richard Colletti, William A Faubion, Samantha Eichner, Yaqin Wang, Andreas Lazar, Roopal B Thakkar, Jeffrey S Hyams

GROWTH IMPROVEMENT IN ADALIMUMAB-TREATED PAEDIATRIC PATIENTS WITH CROHN’S DISEASE: DATA FROM IMAGINE 1

Thomas D Walters, William A Faubion, Anne Griffiths, Robert Baldassano, Frank Ruemmele, Jeffrey S Hyams, Andreas Lazar, Samantha Eichner, Brandee L Pappalardo, Roopal B Thakkar

IMPACT OF DISEASE DURATION ON CLINICAL OUTCOMES WITH ADALIMUMAB TREATMENT IN PATIENTS FROM IMAGINE 1

Jeffrey S Hyams, Frank Ruemmele, Samantha Eichner, Andreas Lazar, Brandee L Pappalardo, Roopal B Thakkar

Item 1 - 10 / 25
1
2 3